|
|
||||||||||||||
|
|
|||||||||||||||
Digestive Diseases
Research Centre, St Bartholomew's and The Royal London School of
Medicine and Dentistry, Turner Street, London E1 2AD, UK
Correspondence to: Dr Turvill.
Accepted for publication 14 April 1999
BACKGROUND
Cholera toxin, and
Escherichia coli heat labile (LT) and heat
stable (STa) enterotoxins induce small intestinal secretion in part by
activating enteric nerves. Igmesine is a novel sigma receptor ligand
that inhibits neurally mediated secretion.
AIMS
To assess the antisecretory
potential of igmesine in cholera toxin, LT, and STa induced water and
electrolyte secretion using an in vivo rat model of jejunal perfusion.
METHODS
After pretreatment with
igmesine, 0.03-10 mg/kg intravenously, jejunal segments of
anaesthetised, adult male Wistar rats were incubated with cholera toxin
(25 µg), LT (25 µg), or saline. Jejunal perfusion with a plasma
electrolyte solution containing a non-absorbable marker was undertaken.
In some cases 200 µg/l STa was added to the perfusate. After
equilibration, net water and electrolyte movement was determined. In
additional experiments rats received igmesine, intravenously or
intrajejunally, after exposure to cholera toxin.
RESULTS
Cholera toxin induced net
water secretion was inhibited by 1 mg/kg igmesine (median
120 versus
31 µl/min/g, p<0.001). LT and STa induced secretion were also
inhibited by 1 mg/kg igmesine (
90 versus
56, p<0.03; and
76
versus
29, p<0.01, respectively). Igmesine reduced established
cholera toxin induced secretion.
CONCLUSION
The sigma ligand,
igmesine, inhibits neurally mediated enterotoxigenic secretion. Its
ability to inhibit established secretion makes it an agent with
therapeutic potential.
This article has been cited by other articles:
![]() |
M J G Farthing Novel targets for the control of secretory diarrhoea Gut, May 1, 2002; 50(90003): iii15 - 18. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |